While the data regarding the possible association between fertility drugs a
nd invasive ovarian cancer are inconclusive, there is evidence to suggest a
n association between induction of ovulation and borderline ovarian tumors.
The plausibility of these results is heightened by the finding that estrog
en receptor expression is a common feature of ovarian borderline tumors. On
the other hand, recent data indicate that in contrast to the crucial role
of germline mutations in the pathogenesis of invasive ovarian cancer, these
mutations play a minor role, if any, in the pathogenesis of borderline ova
rian tumors. This evidence suggests that the differences between invasive a
nd borderline ovarian tumors are not based on minor morphological criteria,
but that, most probably these represent two different entities, with diffe
rent clinical behavior, and that borderline tumors might be associated with
hormonal factors rather than genetic mutations. (C) 1999 Elsevier Science
Ireland Ltd. All rights reserved.